Possible sertraline-induced extrapyramidal adverse effects in an adolescent
Lian-fang Wang,1 Jin-wen Huang,1 Si-yang Shan,2 Jia-hong Ding,3 Jian-bo Lai,1,2 Yi Xu,1,4 Shao-hua Hu1,4 1Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, 2Faculty of Clinical Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, Peopl...
Guardado en:
Autores principales: | Wang LF, Huang JW, Shan SY, Ding JH, Lai JB, Xu Y, Hu SH |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8e2394d4c2d74ed592bbcc5c6ed8eea2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Orexin/Hypocretin Type 2 Receptor (HCRTR2) Gene as a Candidate Gene in Sertraline-Associated Insomnia in Depressed Patients
por: Firouzabadi N, et al.
Publicado: (2020) -
Selective serotonin reuptake inhibitors may lead to improved cataract surgery outcomes in patients with amblyopia
por: Xin KZ, et al.
Publicado: (2019) -
A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
por: Zhong Z, et al.
Publicado: (2017) -
The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
por: McIntyre RS
Publicado: (2017) -
Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
por: Najmeh Shahini, et al.
Publicado: (2021)